JIN MEDICAL INTERNATIONAL-A
ZJYLNASDAQTrading Snapshot
- Day Range
- $939.14 β $970.26
- 52-Week Range
- $1.53 β $12.00
- Volume
- $3.30B
- Avg Volume
- $2.87B
- Shares Outstanding
- 7.8M
- Next Earnings
- Nov 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $21M
- Last Q Revenue
- $9M
- P/E Ratio
- 123.4
- P/S Ratio
- 7.1x
- EPS (TTM)
- $0.15
- Dividend Yield
- β
- Dilution (1yr)
- +0.0%
Why Investors Own ZJYL
- βHigh-growth profile β revenue up +37.4% YoY with expanding US Equity exposure.
- βHealthy economics β 67% gross margin and 28% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
JIN MEDICAL INTERNATIONAL-A
ZJYLAbout JIN MEDICAL INTERNATIONAL-A
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
JIN MEDICAL INTERNATIONAL-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ZJYL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
JIN MEDICAL INTERNATIONAL-A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.